2021
DOI: 10.3390/cells10112995
|View full text |Cite
|
Sign up to set email alerts
|

Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models

Abstract: Traumatic injury of the spinal cord (SCI) is a devastating neurological condition often leading to severe dysfunctions, therefore an improvement in clinical treatment for SCI patients is urgently needed. The potential benefits of transplantation of various cell types into the injured spinal cord have been intensively investigated in preclinical SCI models and clinical trials. Despite the many challenges that are still ahead, cell transplantation alone or in combination with other factors, such as artificial ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 199 publications
(242 reference statements)
0
12
0
Order By: Relevance
“…It not only brings great physical and emotional burdens to the patients and their families but also puts enormous pressure on the clinical management and society as a whole (GBD 2016Neurology Collaborators, 2019Lee et al, 2014;Rubiano et al, 2015). In the past few decades, exciting progress has been made in understanding the pathophysiology of SCI, which has resulted in better treatment paradigms (Cadotte & Fehlings, 2013;David et al, 2019;Fouad et al, 2021;Sofroniew, 2018;Zawadzka et al, 2021). However, the therapeutic effect on clinical patients has not yet achieved satisfactory results and a huge global challenge for the treatment of SCI still exists (Filli & Schwab, 2012;Selvarajah et al, 2015;Hejrati & Fehlings, 2021;Squair et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…It not only brings great physical and emotional burdens to the patients and their families but also puts enormous pressure on the clinical management and society as a whole (GBD 2016Neurology Collaborators, 2019Lee et al, 2014;Rubiano et al, 2015). In the past few decades, exciting progress has been made in understanding the pathophysiology of SCI, which has resulted in better treatment paradigms (Cadotte & Fehlings, 2013;David et al, 2019;Fouad et al, 2021;Sofroniew, 2018;Zawadzka et al, 2021). However, the therapeutic effect on clinical patients has not yet achieved satisfactory results and a huge global challenge for the treatment of SCI still exists (Filli & Schwab, 2012;Selvarajah et al, 2015;Hejrati & Fehlings, 2021;Squair et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…The damage caused by spinal cord injury can lead to a cascade of bio-molecular events, which starts with tissue bruising or tearing caused by mechanical damage that leads to the disruption of the nerve fibers and blood vessels, deterioration of nerve and glial cells, ischemia, and tissue edema [ 25 ]. Following the initial impact, the various bio-molecular events, such as edema, inflammation, neuronal and glial necrosis, or apoptosis can spread beyond the initial site of injury, but ultimately generate a necrotic zone surrounded by glial/fibrotic scarring.…”
Section: General Characteristics Of the Tsci Cellular Biologymentioning
confidence: 99%
“…These roles include modulating inflammatory response, providing nutritional support, regenerating lost neural circuitries, and remyelinating denuded axons, which can improve symptoms (Zawadzka et al, 2021). Cells such as neural stem cells (NSCs), mesenchymal stem cells (MSCs), Schwann cells (SCs), and OECs have been shown…”
Section: Introductionmentioning
confidence: 99%